Research links pharmaceutical board composition with recall timing, while FDA guidance shows why a decision must translate into an effective operating response.
Read MoreLatest Articles
Young audiences favor new actors over influencers in UCLA survey
02:00, October 22, 2026
Added-sugar labels can change which foods shoppers buy
01:00, October 22, 2026
Stanford’s thermal-noise research advances low-power wireless sensing
20:00, October 21, 2026
Connected-car security risks increasingly sit in apps and cloud services
19:20, October 21, 2026
A freelancer’s financial guarantee can make a bid less attractive
18:40, October 21, 2026
A housing slump can change store shelves far beyond the downturn
18:00, October 21, 2026
Europe’s cheaper solar imports bring a manufacturing trade-off
20:10, October 20, 2026
Annual price reviews lose ground in regional Fed survey
19:30, October 20, 2026
Europe’s startup funding gap grows after the early rounds
18:50, October 20, 2026
Business data sharing has a funding problem beyond the technology
18:10, October 20, 2026
Why strong headline earnings growth needs a closer look
17:20, October 19, 2026
Why a supply-chain backup plan can fail when disruption strikes
16:40, October 19, 2026